English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/181859
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Synthesis of enantiopure drugs and drug intermediates by immobilized lipase-catalysis

AuthorsBrabcová, Jana; Filice, Marco ; Gutarra, Melissa; Palomo, José Miguel
Chemical modification
Asymmetric transformation
Kinetic resolution
Issue Date2013
PublisherBentham Science Publishers
CitationCurrent Bioactive Compounds 9(2): 113-136 (2013)
AbstractEnantiomerically pure product synthesis plays a key role in production of pharmaceuticals. The application of biocatalytic approaches represents a convenient and sustainable way for this purpose. The enormous potential of enzymes for the transformation of synthetic chemicals with high chemo-, regio- and enantioselectivity is on increasing awareness. In particular, lipases show a high versatility to recognize non-natural substrates being successfully applied in regio- and stereoselective biotransformations. The immobilization technology on lipases is not only a requisite for the industrial implementation but it has been a great methodology to alter their catalytic properties to obtain highly enantio- and regiose-lective biocatalysts in the enantioselective synthesis of chiral drugs or drug intermediates. This review focuses on showing some of the latest advances on the use of immobilized lipases on pharmaceutical biotransformations.
Publisher version (URL)https://doi.org/10.2174/22115528112019990009
Appears in Collections:(ICP) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.